Intravenous tissue plasminogen activator and stroke in the elderly

American Journal of Emergency Medicine

Volumn 28, Issue 3, 2010, Pages 359-363

  Longstreth Jr , W T ^a   Katz, Ronit ^a   Tirschwell, David L ^a   Cushman, Mary ^b,c   Psaty, Bruce M ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF VERMONT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; TISSUE PLASMINOGEN ACTIVATOR;

AGED; ARTICLE; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG USE; FEMALE; HOSPITALIZATION; HUMAN; MALE; MEDICAL RECORD; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; TREATMENT OUTCOME;

AGED, 80 AND OVER; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; LONGITUDINAL STUDIES; MALE; PLACEBOS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; STROKE; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME; UNITED STATES;

EID: 77649202948     PISSN: 07356757     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajem.2009.01.025     Document Type: Article

References (15)

1. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 333 (1995) 1581-1587
2. Wardlaw J.M., Zoppo G., Yamaguchi T., et al. Thrombolysis for acute ischaemic stroke. Cochrane Database Syst Rev (2003) CD000213
3. Fried L.P., Borhani N.O., Enright P., et al. The Cardiovascular Health Study: design and rationale. Ann Epidemiol 1 (1991) 263-276
4. Longstreth Jr. W.T., Bernick C., Fitzpatrick A., et al. Frequency and predictors of stroke death in 5,888 participants in the Cardiovascular Health Study. Neurology 56 (2001) 368-375
5. Kwiatkowski T.G., Libman R.B., Frankel M., et al. Effects of tissue plasminogen activator for acute ischemic stroke at one year. National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study Group. N Engl J Med 340 (1999) 1781-1787
6. Engelter S.T., Bonati L.H., and Lyrer P.A. Intravenous thrombolysis in stroke patients of > or =80 versus <80 years of age-a systematic review across cohort studies. Age Ageing 35 (2006) 572-580
7. Meseguer E., Labreuche J., Olivot J.M., et al. Determinants of outcome and safety of intravenous rt-PA therapy in the very old: a clinical registry study and systematic review. Age Ageing 37 (2008) 107-111
8. Uyttenboogaart M., Schrijvers E.M., Vroomen P.C., et al. Routine thrombolysis with intravenous tissue plasminogen activator in acute ischaemic stroke patients aged 80 years or older: a single centre experience. Age Ageing 36 (2007) 577-579
9. Gomez-Choco M., Obach V., Urra X., et al. The response to IV rt-PA in very old stroke patients. Eur J Neurol 15 (2008) 253-256
10. Toni D., Lorenzano S., Agnelli G., et al. Intravenous thrombolysis with rt-PA in acute ischemic stroke patients aged older than 80 years in Italy. Cerebrovasc Dis 25 (2008) 129-135
11. Zeevi N., Chhabra J., Silverman I.E., et al. Acute stroke management in the elderly. Cerebrovasc Dis 23 (2007) 304-308
12. De Keyser J., Gdovinova Z., Uyttenboogaart M., et al. Intravenous alteplase for stroke: beyond the guidelines and in particular clinical situations. Stroke 38 (2007) 2612-2618
13. Arora S., Broderick J.P., Frankel M., et al. Acute stroke care in the US: results from 4 pilot prototypes of the Paul Coverdell National Acute Stroke Registry. Stroke. 36 (2005) 1232-1240
14. Schumacher H.C., Bateman B.T., Boden-Albala B., et al. Use of thrombolysis in acute ischemic stroke: analysis of the Nationwide Inpatient Sample 1999 to 2004. Ann Emerg Med 50 (2007) 99-107
15. Barber P.A., Zhang J., Demchuk A.M., et al. Why are stroke patients excluded from TPA therapy? An analysis of patient eligibility. Neurology 56 (2001) 1015-1020